Menu

FAQ Directory: HEDIS

Filter Results
  • Save
  • Email
  • Print

10.15.2019 Supplemental Data and Rules for Allowable Adjustments In some cases, supplemental data are not allowed for regular HEDIS reporting, but may supplemental data sources be used when following the Rules for Allowable Adjustments?

Yes. Supplemental data may be used for the denominator and the numerator when following the Rules for Allowable Adjustments. In general, the data are usable when the codes are in the value sets and the clinical intent of the measure is not changed, but there are restrictions for use of supplemental data in regular HEDIS reporting:

  1. For denominator calculation. The current restriction in regular HEDIS reporting is based on auditability, not on the data’s effect on the measure’s clinical intent. In Allowable Adjustments, files may be used if they meet all measure requirements.
  2. For Numerator calculation. The current restriction in regular HEDIS reporting is based on assessing paid claims vs. denied claims. In Allowable Adjustments, files may be used if they meet all requirements of the measure, even if the organization cannot determine payment status.

HEDIS 2020

9.16.2019 Cutoff Date for NDCs in the HEDIS 2020 MLD What is the cutoff date for including National Drug Codes (NDCs) in the HEDIS 2020 Medication List Directory (MLD)?

Any NDC or RxNorm code that is in the U.S. National Library of Medicine’s RxNorm database as of September 1, 2019 will be considered for inclusion in the HEDIS 2020 MLD, which will be posted to the NCQA website on November 1, 2019. This is a change from past years’ cutoff date, which was September 30.

HEDIS 2020

4.15.2019 SES Guidance in Technical Update The SES stratification guidance in the HEDIS 2019 Volume 2 Technical Update Memo indicates that the “Unknown” category may be used for only Puerto Rico plans or if the auditor approves a small number of unassigned members. Is there a specific number of Unknown members a plan is allowed to report?

Except for plans in Puerto Rico, which report all members in the “Unknown” category, it is expected that the member count in this category will be fewer than 10. Plans should determine why members are reported as “Unknown” and be able to explain the reason to their auditor.

This category should not be used for members who are disenrolled for the 2019 calendar year and consequently have no record in the December 2018 Monthly Membership Detail File. Use the October and November files for these members.

HEDIS 2019

4.15.2019 No Benefit Designation How does an organization determine if the No Benefit designation is appropriate for reporting?

General Guideline 25 in HEDIS Volume 2 explains that benefits are not assessed at the service level. Assessment of benefits must follow the measure specifications under the Benefit section of the Eligible Population criteria. Organizations may not assess benefits at a service level for an NB (No Benefit) audit designation. 

For example:

·    If the organization offers a pharmacy benefit but does not cover a specific medication class, the member has a pharmacy benefit and is included in the applicable measures requiring this benefit.

·    If the organization offers a mental health benefit but does not cover inpatient visits, the member has a mental health benefit and is included in the applicable measures requiring this benefit, unless the measure benefit requires inpatient care, per the Eligible Population benefit requirements (e.g., Follow-up After Hospitalization for Mental Illness requires both inpatient and outpatient mental health coverage).

HEDIS 2019

2.15.2019 Plan All-Cause Readmissions (PCR) The “Total” data elements for Medicare in Table PCR-A must match the “Total Medicare” data elements in Table PCR-B. Are organizations required to report the totals in both tables?

No. Organizations only need to report the “Total” data elements for Medicare in Table PCR-A. Remove the “Total Medicare” row from Table PCR-B that is used for the SES Stratifications. The duplicate data elements were removed in the Interactive Data Support System (IDSS) and the data will only be collected in Table PCR-A. The asterisked language may also be removed under these two tables.

HEDIS 2019

2.15.2019 Plan All-Cause Readmissions (PCR) The “Total” data elements for Medicare in Table PCR-C must match the “Total Medicare” data elements in Table PCR-D. Are organizations required to report the totals in both tables?

No. Organizations only need to report the “Total” data elements for Medicare in Table PCR-C. Remove the “Total Medicare” row from Table PCR-D that is used for the SES Stratifications. The duplicate data elements were removed in the Interactive Data Support System (IDSS) and the data will only be collected in Table PCR-C. The asterisked language may also be removed under these two tables.

HEDIS 2019

2.15.2019 Supplemental Data When pharmacy data are classified as supplemental data, the following data elements must be present: the generic name (or brand name), strength/dose, route and date when the medication was dispensed to the member. If all the required data elements are included except the dispense date, can a start date be used instead?

No. When pharmacy data are used as supplemental data, a dispense date is required; a start date may not be used as a proxy. There are no exceptions to the requirements for pharmacy data, as described in General Guideline 30.

HEDIS 2019

1.15.2019 Death as an Exclusion in HEDIS Is death a valid exclusion for HEDIS measures?

NCQA expects plans to disenroll deceased members. Members who died during the continuous enrollment period would not meet the measure’s eligible population criteria (e.g., continuous enrollment and anchor date requirements) and would not be included in the measure denominator. However, a member who meets the continuous enrollment criteria remains in the measure. For example, when reporting the MRP measure, a member who was discharged on July 1 and died on August 1, but enrollment data indicates the member is enrolled in the organization during the continuous enrollment period (the date of discharge through 30 days after discharge) must remain in the measure.

Keep in mind that organizations may not use other data sources (e.g., medical record data) when removing deceased members.
 

HEDIS 2019

1.15.2019 Medication Management for People With Asthma (MMA) and Adherence to Antipsychotic Medications for Individuals With Schizophrenia (SAA) In HEDIS 2019, step 4 of the numerator calculation was revised to indicate that the ratio should be rounded to the nearest whole number using the .5 rule. Should the value that is calculated using the formula in the measure be multiplied by 100 before rounding to the nearest whole number using the .5 rule?

Yes. The new rounding directions in step 4 are meant to treat the calculated decimal result as a whole number from 0%–100% for the SAA and MMA measures. For example, if a member has 291 total days covered by a medication during a 365-day treatment period, this calculates to 0.7972. Multiply this number by 100, convert it to 79.72% and round it to 80%, the nearest whole number.

HEDIS 2019

1.15.2019 Risk of Continued Opioid Use (COU) When calculating the number of days covered for the COU measure’s numerators, must the days be consecutive?

No. The covered days are not required to be consecutive when reporting the numerators of the measure. Review all dispensed opioids on the IPSD through the 30-day or 62-day period and follow the instructions for calculating number of days covered for the numerator. For example, if the IPSD is 1/1/18 and the member has an eligible prescription with a 5-day supply and another eligible prescription with a 10-day supply on 1/10/18, the member meets criteria for the ≥15 Days Covered numerator.
 

HEDIS 2019

1.15.2019 Adult BMI Assessment (ABA) There was a change to the ICD-10 coding guidelines, effective October 1, 2018, related to the codes for reporting body mass index (BMI). The change allows providers to bill for BMI codes only if the member has a clinically relevant condition, such as obesity. How does this change affect reporting the ABA measure?

The ICD-10 coding change affects only the administrative-reporting method. Following the new guidelines, a provider would submit a claim with a BMI or BMI percentile code only when there is an associated diagnosis (e.g., overweight, obesity) that meets the new requirements. “Healthy weight” is not considered an associated diagnosis. As a result, members in the denominator, whose only visit is in October, November, or December of 2018, without an appropriate ICD-10 code, due to the lack of an associated diagnosis, will not have claims that meet the current numerator criteria.

NCQA’s analysis shows that, because this measure is reported primarily through the hybrid-reporting option, the effect will be small. This change does not affect organizations using the hybrid method, because the rule pertains to only the use of ICD-10 codes on claims. It does not prohibit providers from measuring and documenting a BMI in the medical record.
 

HEDIS 2019

1.15.2019 Comprehensive Diabetes Care (CDC) If documentation in a 2018 visit note indicates “No Diabetic Retinopathy as of Ophtho note on 9/2017,” does this meet criteria as a negative retinal exam?

Yes. This meets criteria for HEDIS 2019 reporting because the documentation indicates that the eye exam was completed by an eye care professional (optometrist or ophthalmologist), the date when the procedure was performed was within the appropriate time frame and the results are present (a negative retinal exam in the year prior to the measurement year).

HEDIS 2019